Tom van Meerten
University Medical Center Groningen(NL)University Medical Center Groningen(NL)University of Groningen(NL)
Publications by Year
Research Areas
CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma(2021)1,430 cited
- → The Biological Activity of Human CD20 Monoclonal Antibodies Is Linked to Unique Epitopes on CD20(2006)600 cited
- → Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma(2023)373 cited
- → Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+ T Cells(2014)281 cited
- → Complement-Induced Cell Death by Rituximab Depends on CD20 Expression Level and Acts Complementary to Antibody-Dependent Cellular Cytotoxicity(2006)244 cited
- → Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma(2021)198 cited